Sarah Ford | November 20, 2014
Drug Restores Memory Function in Alzheimer’s Model
Building on earlier work funded by BrightFocus, researchers have discovered a promising new drug compound that reverses some
Alzheimer’s effects on memory in mice.
Four years ago, a research team led by BrightFocus grantee and Nobel Laureate Dr. Paul Greengard established the connection between increased striatal-enriched tyrosine phosphatase (STEP) levels and Alzheimer’s changes in mice, and showed that removing STEP had the effect of restoring synaptic connections.
Since their discovery of STEP, this research team has been searching for a drug that would block its damaging effects on brain synapses. They focused their efforts on finding a STEP inhibitor, studying thousands of small molecules in their quest.
Get Resources and Insights Straight To Your Inbox
Explore More Articles
Open Position: Customer Service Coordinator (Remote-Part Time)
Position Title: Customer Service Coordinator (Remote – Part Time) Department: Charitable Funds Management Solutions We are a non-profit charitable organization looking for skilled individuals who…
Read Article
National Alzheimer’s Disease Awareness Month
President Ronald Reagan designated November as Alzheimer’s Disease Awareness Month in 1983 when there were less than two million people suffering from the disease. Since…
Read Article
National Scholarship Month/National Education Month
National Scholarship Month/National Education Month aims to build awareness of scholarships and opportunities in higher education. Established in 1998, it recognizes communities, organizations, and businesses within the…
Read ArticleGet Resources and Insights Straight To Your Inbox
Receive our monthly/bi-monthly newsletter filled with information about causes, nonprofit impact, and topics important for corporate social responsibility and employee engagement professionals, including disaster response, workplace giving, matching gifts, employee assistance funds, volunteering, scholarship award program management, grantmaking, and other philanthropic initiatives.
